Related Experiment Video
Updated: Aug 23, 2026

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
Published on: April 10, 2016
Proteolytic activity in Serratia marcescens clinical isolates
R Coria-Jiménez1, C Zárate-Aquino, O Ponce-Ponce
1Laboratory of Experimental Bacteriology, National Institute of Pediatrics, México City, 04530 México. rafaelcoria@yahoo.com
Abstract:
Exoproteinase production was demonstrated in 64 clinical isolates of S. marcescens. A significant relationship was found between the site of origin (autopsy material, hemocultures, various other sources), proteinase activity, and LD50 of the analyzed isolates. The number of exoproteinases varied during a 14-h incubation in batch cultures; the most frequently found was a 57.5-kDa proteinase which was observed in all analyzed strains. The exoproteinase production was shown to be related to strain virulence.
Insights
Clinical isolates of Serratia marcescens (S. marcescens) produce exoproteinases linked to virulence. Proteinase activity and origin site correlated with lethal dose 50 (LD50), with a common 57.5-kDa enzyme found in all strains.
Area of Science:
- Microbiology
- Molecular Biology
- Pathogenesis
Background:
- Serratia marcescens (S. marcescens) is an opportunistic pathogen.
- Exoproteinases are virulence factors in many bacteria.
- Understanding S. marcescens exoproteinase production is crucial for assessing its pathogenic potential.
Purpose of the Study:
- To investigate exoproteinase production in clinical isolates of S. marcescens.
- To determine the relationship between exoproteinase activity, site of origin, and virulence (LD50).
- To characterize the exoproteinases produced by these isolates.
Main Methods:
- Analysis of 64 clinical isolates of S. marcescens.
- Quantification of exoproteinase activity.
- Determination of lethal dose 50 (LD50) for virulence assessment.
- Monitoring exoproteinase production over a 14-hour incubation period.
Main Results:
- Exoproteinase production was confirmed in all 64 clinical isolates.
- A significant correlation was observed between the site of origin, proteinase activity, and LD50.
- Exoproteinase production varied during incubation, with a 57.5-kDa proteinase consistently detected in all strains.
- Exoproteinase production was directly related to S. marcescens strain virulence.
Conclusions:
- Exoproteinase production is a common characteristic of clinical S. marcescens isolates.
- The level of exoproteinase activity and specific enzyme profiles are associated with bacterial virulence.
- These findings highlight the role of exoproteinases in S. marcescens pathogenesis.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Determinants of Bacterial Pathogenicity and Virulence

